Protein Aggregation - Part B (Volume 146) (Advances in Protein Chemistry and Structural Biology, Volume 146)

-

ISBN 10: 0443430969 / ISBN 13: 9780443430961

Published by Academic Press -, 2025

About this Item

Seller Inventory # 6666-GRD-9780443430961

Bibliographic Details

• Title: Protein Aggregation - Part B (Volume 146) (Advances in Protein Chemistry and Structural Biology, Volume 146)
• Publisher: Academic Press -
• Publication Date: 2025
• Language: English
• ISBN 10: 0443430969
• ISBN 13: 9780443430961
• Binding: hardcover
• Condition: New

About this title

Synopsis

Protein Aggregation - Part B, provides valuable insights into the factors driving protein aggregation, the impact on cellular function, and the role in various diseases, offering a comprehensive overview for researchers and professionals in the field of biomedicine and biochemistry.

• Provides the latest information on cancer research
• Offers outstanding and original reviews on a range of cancer research topics
• Serves as an indispensable reference for researchers and students alike

About the Author

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.